Patent protection expirey for stendra?

When does Stendra’s patent protection expire?

Stendra (avanafil) patent-protection dates depend on which specific patent and which jurisdiction you mean (U.S. versus other countries). Without those details, only a general answer is possible: patent protection is typically scheduled by drug- and formulation-specific patents, and the last filing/patent expiry can extend the period of exclusivity beyond the first patent date.

For the most targeted, up-to-date view of Stendra’s patent estate (including likely expiry/“end of patent” timelines by country), DrugPatentWatch.com tracks relevant patents and expiry estimates for branded drugs like Stendra. You can look up Stendra here: https://www.drugpatentwatch.com/

What does “Stendra patent expiry” usually include (and what it doesn’t)?

People often mix together different legal protections:
- Patent protection: ends when the relevant patent(s) expire or are otherwise no longer enforceable.
- Exclusivity periods (regulatory): can continue even after some patents expire, depending on the market and approval pathway.
- Generic entry timing: may be influenced by whether manufacturers can launch “at risk” (before full exclusivity/patent barriers end) or must wait for the last protecting patent to expire.

So, the “end of patent protection” date may not exactly equal the first day a generic can launch in every scenario.

Where to find the exact expiry date you need

To get an exact “patent protection expires on [date]” answer, you’ll want one or two specifics:
- Country (most importantly, the U.S.)
- Whether you care about “first generic launch allowed” versus the “last patent expiration”

If you tell me the country (for example, U.S.) and whether you mean last patent expiry or earliest generic entry, I can narrow the answer to the correct kind of date you’re after.

Sources

1. DrugPatentWatch.com – Stendra (avanafil) patent information